Replicate designs and average, individual and population bioequivalence: I. estimation, inference and retrospective assessment of performance of novel procedures and the proposed FDA methods for bioequivalence assessment

The design and analysis of multicentre trials in the random effects setting

Pharmacokinetic bridging and ICH-E5 : Retrospective and simulation assessment of proposals for pharmacokinetic equivalence assessment between independent populations

Replicate designs and average, individual and population bioequivalence: II. Simulation asessment of performance of novel procedures and the proposed FDA methods for bioequivalence assessment

The construction of universally optimal uniform cross-over designs

Return to DDS Technical Reports